UCHL1 and breast cancer: Additionally, increased UCH-L1 levels in advanced breast cancer patients who did not respond to chemotherapy led to overexpression of epidermal growth factor receptor (EGFR) and an increase in cancer cell invasion, metastasis and shortened the rate of survival [78].